HIC gene, a candidate suppressor gene within a minimal region of loss at 7q31.1 in myeloid neoplasms

Leukemia Research

Volumn 31, Issue 4, 2007, Pages 477-482

  Cigognini, Daniela ^a   Corneo, Gianmarco ^b   Fermo, Elisa ^c   Zanella, Alberto ^c   Tripputi, Pasquale ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Acute myeloid leukemia; Chromosome 7; Deletion; DNA; Human I mfa domain containing protein; MDFIC; Myelodysplasia

Indexed keywords

MYOD PROTEIN;

ARTICLE; CANCER GENETICS; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; EXON; GENE LOSS; GENE MUTATION; HIC GENE; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; MARKER GENE; MICROSATELLITE MARKER; MONOSOMY; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN FAMILY; TUMOR SUPPRESSOR GENE;

ACUTE DISEASE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 7; DNA, NEOPLASM; EXONS; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, MYELOID; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MONOSOMY; MUTATION; MYOGENIC REGULATORY FACTORS; POLYMERASE CHAIN REACTION;

EID: 33846807842     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.09.007     Document Type: Article

References (40)

1. Leith C.P., Kopecky K.J., Godwin J., McConnell T., Slovak M.L., and Chen I.M. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 89 (1997) 3323-3329
2. Rund D., and Ben-Yehuda D. Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment. Hematology 9 (2004) 179-187
3. Dabaja B.S., Fader S., Thomas D., Cortes J., O'Brien S., Nasr F., et al. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications. Leukemia 13 (1999) 869-872
4. Anastasi J. Molecular cytogenetics and the myelodysplastic syndromes. Leuk Res 20 (1996) 559-562
5. van der Straaten H.M., van Biezen A., Brand R., Schattenberg A.V., Egeler R.M., Barge R.N., et al. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities. Haematologica 90 (2005) 1339-1345
6. Le Beau M.M., Espinosa III R., Davis E.M., Eisenbart J.D., Larson R.A., and Green E.D. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 88 (1996) 1930-1935
7. Andersen C.L., Gruszka-Westwood A., Ostergaard M., Koch J., Jacobsen E., Kjeldsen E., et al. A narrow deletion of 7q is common to HCL and SMZL, but not CLL. Eur J Haematol 72 (2004) 390-402
8. Liang H., Fairman J., Claxton D.F., Nowell P.C., Green E.D., and Nagarajan L. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci USA 95 (1998) 3781-3785
9. Tripputi P., Cassani B., Alfano R., Graziani D., Cigognini D., Doi P., et al. Chromosome 7 monosomy and deletions in myeloproliferative diseases. Leuk Res 25 (2001) 735-739
10. Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.A., et al. Human chromosome 7: DNA sequence and biology. Science 300 (2003) 767-772
11. Tatarelli C., Linnebach A., Mimori K., and Croce C.M. Characterization of the human TESTIN gene localizated in the FRA7G region at 7q31.2. Genomocs 68 (2000) 1-12
12. Engelman J.A., Zhang X., Galbiati F., Volonte D., Sotgia F., Pestell R.G., et al. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease and muscular dystrophy. Am J Hum Genet 63 (1998) 1578-1587
13. Rehli M., Lichanska A., Cassady A., Ostrowski M.C., and Hume D.A. TFEC is a macrophage-restricted member of the microphthalmia-TFE subfamily of basic helix-loop-helix leucine zipper transcription factors. J Immunol 162 (1999) 1559-1565
14. Furge K.A., Zhang Y.W., and Vandewoude G.F. MET receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 19 (2000) 5582-5590
15. Thébault S., Gachon F., Lemasson I., Devaux C., and Mesnard J.M. Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type 1 and HIV-1 expression. J Biol Chem 275 (2000) 4848-4857
16. Kusano S., and Raab-Traub N. I-mfa domain proteins interact with axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Mol Cell Biol 22 (2002) 6393-6405
17. Young T.M., Wang Q., Pe'ery T., and Mathews M.B. The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription. Mol Cell Biol 23 (2003) 6373-6384
18. Gautier V.W., Sheehy N., Duffy M., Hashimoto K., and Hall W.W. Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activity. PNAS 102 (2005) 16362-16367
19. Liang H., Castro P.D., Ma J., and Nagarajan L. Finer delineation and transcript map of the 7q31 locus deleted in myeloid neoplasms. Cancer Genet Cytogen 162 (2005) 151-159
20. Tripputi P., Emanuel B.S., Croce C.M., Green L., Stein G.S., and Stein J.L. Human histone genes map to multiple chromosomes. Proc Natl Acad Sci USA 83 (1986) 3185-3188
21. Tripputi P., Guerin S., and Moore D.D. Two mechanisms for extinction of gene expression in hybrid cells. Science 241 (1988) 1205-1208
22. Tripputi P., Graziani D., Alfano R.M., Cassani B., and Coggi G. A common T/C polymorphism in the promoter region of the beta T-cell receptor gene. Mol Cell Probes 14 (2000) 195-197
23. Tripputi P., Baciocchi G., Accolla R.S., Mantero G., DeBellis G., Manoni M., et al. Detection of human chromosomes in somatic cell hybrids by PCR anlysis. Cytogenet Cell Genet 62 (1993) 1-4
24. Tripputi P., Blasi F., Verde P., Cannizzaro L.A., Emanuel B.S., and Croce C.M. Human urokinase gene is located on the long arm of chromosome 10. Proc Natl Acad Sci USA 82 (1885) 4448-4452
25. Engelman J.A., Zhang X.L., and Lisanti M.P. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett 448 (1999) 221-230
26. Zenklusen J.C., Weitzel J.N., Ball H.G., and Conti C.J. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene 11 (1995) 359-363
27. Zenklusen J.C., Hodges L.C., LaCava M., Green E.D., and Conti C.J. Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site. Oncogene 19 (2000) 1729-1733
28. Williams T.M., and Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288 (2005) 494-506
29. Cui J., Rohr L.R., Swanson G., Speights V.O., Maxwell T., and Brothman A.R. Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 46 (2001) 249-256
30. Tobias E.S., Hurlstone A.F., MacKenzie E., McFarlane R., and Black D.M. The TES gene at 7q31.1 is methylated in tumors and encodes a novel growth-suppressing LIM domain protein. Oncogene 20 (2001) 2844-2853
31. Chene L., Giroud C., Desgrandchamps F., Boccon-Gibod L., Cussenot O., Berthon P., et al. Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. Int J Cancer 111 (2004) 798-804
32. Sarti M., Sevignani C., Calin G.A., Aqeilan R., Shimizu M., Pentimalli F., et al. Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo. Clin Cancer Res 11 (2005) 806-813
33. Tatarelli C., Linnebach A., Mimori K., and Croce C. Characterization of the human TESTIN gene localizated in the FRA7G region at 7q31.2. Genomics 68 (2000) 1-12
34. Kuiper R.P., Schepens M., Thijssen J., Schoenmakers E.F.P.M., and van Kessel A.G. Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. Nucleic Acid Res 32 (2004) 2315-2322
35. Zhao G., Zhao Q., Zhou X., Mattei M., and de Crombrugge B. TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation. Mol Cell Biol 13 (1993) 4505-4512
36. Rehli M., Lichanska A., Cassady A.I., Ostrowski M.C., and Hume D.A. TFEC is a macrophage-restricted member of the microphthalmia-TFE subfamily of basic helix-loop-helix leucine zipper transcription factors. J Immunol 162 (1999) 1559-1565
37. Matsunaga M., Ishida T., Takenawa M., Nishimura S., Adachi M., and Imai K. Analysis of gene expression during maturation of immature dendritic cells derived from peripheral blood monocytes. Scand J Immunol 56 (2002) 593-601
38. Rehli M., Sulzbacher S., Pape S., Ravasi T., Wells C.A., Heinz S., et al. Transcription factor Tfec contributes to the IL-4-inducibile expression of a small group of genes in mouse macrophages including the granulocyte colony-stimulating factor receptor. J Immunol 174 (2005) 7111-7122
39. Thébault S., and Mesnard J.M. How the sequestration of a protein interfers with its mechanism of action: example of a new family of proteins characterized by a particular cysteine-rich carboxy-terminal domain involved in gene expression regulation. Curr Protein Pept Sci 2 (2001) 155-167
40. Snider L., Thirlwell H., Miller J.R., Moon R.T., Groudine M., and Tapscott S.J. Inhibition of Tcf3 binding by I-mfa proteins. Mol Cell Biol 21 (2001) 1866-1873